The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS database
Background: The promise of immune checkpoint inhibitors (ICIs) therapy in cancer treatment is tempered by the occurrence of immune-related adverse events (irAEs). Many patients undergoing ICIs also take aspirin, but the association between aspirin and irAEs is not well understood.Methods: This study...
Main Authors: | Huaju Yang, Zheran Liu, Ruidan Li, Rendong Huang, Xingchen Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1259628/full |
Similar Items
-
Association between statin use and immune-related adverse events in patients treated with immune checkpoint inhibitors: analysis of the FAERS database
by: Huaju Yang, et al.
Published: (2024-10-01) -
Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency
by: Jing Xiang, et al.
Published: (2023-12-01) -
Meta‐analysis of immune‐related adverse events of immune checkpoint inhibitor therapy in cancer patients
by: Peng Song, et al.
Published: (2020-09-01) -
Management of immune checkpoint inhibitor‐related dermatologic adverse events
by: Xiaoyan Si, et al.
Published: (2020-02-01) -
Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis
by: Céline Eldani, et al.
Published: (2024-07-01)